Subscribe to RSS
DOI: 10.1055/s-2007-967091
The Use of i. v. Bisphosphonate in Pregnancy-Associated Osteoporosis - Case Study
Publication History
received 20. 12. 2005
first decision 29. 05. 2006
accepted 2. 06. 2006
Publication Date:
22 February 2007 (online)


Abstract
Objective: Diagnosis of pregnancy-associated osteoporosis is often delayed and therapeutic interventions insufficient.
Study design: A 28-year-old patient (BMI=18.6) with no additional risks for osteoporosis experienced acute lumbosacral pain two months postpartum, while lactating. After conservative therapy, thoracic and lumbar spine were X-rayed: severe pregnancy-associated osteoporosis with vertebral fractures was diagnosed. 2-year treatment with i. v. bisphosphonate ibandronate was initiated (2 mg every 3 months) and calcium and vitamin D supplementation.
Results: Rapid improvement was observed. Conclusion: In cases with multiple fractures i. v. bisphosphonate leads to substantial decrease of symptoms and further fractures and significant increase of bone mass density (BMD).
Conclusion: In severe cases of pregnancy-associated osteoporosis with multiple fractures i. v. biphosphonate therapy leads to a decrease of symptoms and fracture risk and an increase of bone mass density (BMD).
Key words
alimentation - hormones - metabolic features